Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritake Iguchi

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|December 16, 2015
Is New-Onset Atrial Fibrillation Bad News for Patients With Heart Failure?Moritake Iguchi, Masaharu Akao
Circulation Journal : Official Journal of the Japanese Circulation Society|March 1, 2019
Underdosing of Direct Oral Anticoagulants　- Pros or Cons?Moritake Iguchi, Masaharu Akao
European Heart Journal. Cardiovascular Pharmacotherapy|November 30, 2023
Are NOACs always the best strategy in elderly AF patients?Moritake Iguchi, Juan Tamargo, Koji Hasegawa
European Cardiology|July 17, 2023
When Should We Start Sodium-Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early InterventionMoritake Iguchi, Hiromichi Wada, Felipe Martínez, et al.
European Cardiology|June 29, 2026
Myosin Inhibition in Non-obstructive Hypertrophic Cardiomyopathy: Lessons from ODYSSEY-HCMKoji Hasegawa, Moritake Iguchi, Hiromichi Wada, et al.
European Cardiology|July 31, 2024
What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?Maki Komiyama, Moritake Iguchi, Hiromichi Wada, et al.
Journal of Pharmacological Sciences|November 5, 2014
Serofendic acid protects against myocardial ischemia-reperfusion injury in ratsTadaaki Ioroi, Masaharu Akao, Moritake Iguchi, et al.
International Journal of Cardiology|February 8, 2011
Direct monitoring of mitochondrial calcium levels in cultured cardiac myocytes using a novel fluorescent indicator protein, GCaMP2-mtMoritake Iguchi, Masashi Kato, Junichi Nakai, et al.
Cardiovascular Research|March 21, 2009
The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imagingMasashi Kato, Masaharu Akao, Madoka Matsumoto-Ida, et al.
ESC Heart Failure|November 23, 2022
Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid-19 vaccine in a middle-aged womanKosuke Kobayashi, Yasuhiro Hamatani, Koki Moriyoshi, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Circulation Journal : Official Journal of the Japanese Circulation Society|December 16, 2015
Is New-Onset Atrial Fibrillation Bad News for Patients With Heart Failure?Moritake Iguchi, Masaharu Akao
Circulation Journal : Official Journal of the Japanese Circulation Society|March 1, 2019
Underdosing of Direct Oral Anticoagulants　- Pros or Cons?Moritake Iguchi, Masaharu Akao
European Heart Journal. Cardiovascular Pharmacotherapy|November 30, 2023
Are NOACs always the best strategy in elderly AF patients?Moritake Iguchi, Juan Tamargo, Koji Hasegawa
European Cardiology|July 17, 2023
When Should We Start Sodium-Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early InterventionMoritake Iguchi, Hiromichi Wada, Felipe Martínez, et al.
European Cardiology|June 29, 2026
Myosin Inhibition in Non-obstructive Hypertrophic Cardiomyopathy: Lessons from ODYSSEY-HCMKoji Hasegawa, Moritake Iguchi, Hiromichi Wada, et al.
European Cardiology|July 31, 2024
What is the Future Position of Factor XIa Inhibitors for Patients with Atrial Fibrillation?Maki Komiyama, Moritake Iguchi, Hiromichi Wada, et al.
Journal of Pharmacological Sciences|November 5, 2014
Serofendic acid protects against myocardial ischemia-reperfusion injury in ratsTadaaki Ioroi, Masaharu Akao, Moritake Iguchi, et al.
International Journal of Cardiology|February 8, 2011
Direct monitoring of mitochondrial calcium levels in cultured cardiac myocytes using a novel fluorescent indicator protein, GCaMP2-mtMoritake Iguchi, Masashi Kato, Junichi Nakai, et al.
Cardiovascular Research|March 21, 2009
The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imagingMasashi Kato, Masaharu Akao, Madoka Matsumoto-Ida, et al.
ESC Heart Failure|November 23, 2022
Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid-19 vaccine in a middle-aged womanKosuke Kobayashi, Yasuhiro Hamatani, Koki Moriyoshi, et al.
Pageof 11